Agreement gives Horizon exclusive right to supply services on Ardaza’s multiplex label-free immunoassay technology.
Adarza BioSystems, Inc. has executed an agreement with SunEdison Semiconductor to establish immunoassay consumable manufacturing facilities at its St. Peters, Missouri manufacturing site.
ROCHESTER, NY: Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed the final tranche of its Series-A financing bringing the total Series-A financing amount to $6.8 million. Proceeds from the financing will be used to launch its first 100-plex immunoassay product consumable and instrument and accelerate [...]
Life Science company expands presence to St. Louis ST. LOUIS, MO: BioGenerator recently led syndication of investment in Adarza BioSystems, Inc., to support further commercialization of the company’s immunoassay products. As part of the investment, Adarza will conduct its primary business and product development in St. Louis as well as its manufacturing activities. Adarza is [...]
ROCHESTER, NY: Adarza BioSystems, Inc. has been awarded a $245,912 Small Business Innovation Research (SBIR) grant from the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH) to aid the company in its efforts to apply its breakthrough Arrayed Imaging Reflectometry (AIRTM) bioassay platform for the detection of environmental toxins in [...]
Missouri Technology Corporation Helps to Recruit Life Science Startup to Missouri with IDEA Funds Program
NEWS RELEASE FROM: Missouri Department of Economic Development Date: Thursday, June 27, 2012 JEFFERSON CITY, MO: The Missouri Technology Corporation (MTC) today announced a significant investment in a life science startup company through its IDEA Funds program. MTC made a $200,000 investment in Adaraza BioSystems, Inc, a life science technology company that has developed a disruptive [...]
ROCHESTER, NY: Adarza BioSystems, Inc. announced today that it has expanded its Board of Directors with the addition of two leading business executives: Dr. Heiner Dreismann, former CEO of Roche Molecular Systems and James Senall, President of High Tech Rochester. Dr. Dreismann brings a wealth of experience, contacts and insight to Adarza as it moves [...]
ROCHESTER, N.Y. – Adarza BioSystems, Inc. announced today that former Roche Molecular Systems CEO, Dr. Heiner Dreismann, an internationally recognized leader in the in vitro diagnostics industry, has joined Adarza’s Board of Directors. Dr. Dreismann brings a wealth of experience, contacts and insight to Adarza as it moves to commercialize its protein multiplex product platform [...]
Having peered into the high-tech future with confidence, Miller and the Adarza team — CEO Rand Henke and chief operating officer Terry Gronwall — now must deal with the timeless issues of the marketplace.
ROCHESTER, NY: Adarza BioSystems, Inc. has been awarded a $244,500 Qualifying Therapeutic Discovery Project grant from the Internal Revenue Service to aid the company in its efforts to apply its breakthrough Arrayed Imaging Reflectometry bioassay platform to the diagnosis and monitoring of bladder cancer. The Qualifying Therapeutic Discovery Program was enacted as part of the [...]